The chief financial officer of Ark Therapeutics Group Plc, Martyn Williams, has become the chief executive following the resignation of the previous incumbent, Nigel Parker, in the aftermath of the withdrawal of Ark’s marketing application for its lead drug, Cerepro.
Copyright 2010 Evernow Publishing Ltd